CRIS Current Research Information System

BARBARA, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.174
EU - Europa 13.667
AS - Asia 13.116
AF - Africa 964
SA - Sud America 935
OC - Oceania 45
AN - Antartide 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 44.903
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.996
IT - Italia 4.569
CN - Cina 4.141
SG - Singapore 4.136
GB - Regno Unito 2.783
VN - Vietnam 2.027
DE - Germania 1.567
HK - Hong Kong 1.061
SE - Svezia 990
IN - India 692
BR - Brasile 673
UA - Ucraina 659
RU - Federazione Russa 618
KR - Corea 461
FR - Francia 452
IE - Irlanda 422
NL - Olanda 373
FI - Finlandia 274
CH - Svizzera 257
CI - Costa d'Avorio 250
ZA - Sudafrica 209
EE - Estonia 180
JP - Giappone 178
TG - Togo 157
NG - Nigeria 152
SC - Seychelles 112
AR - Argentina 110
JO - Giordania 109
AT - Austria 103
BG - Bulgaria 84
CA - Canada 84
ID - Indonesia 83
BE - Belgio 71
MX - Messico 59
ES - Italia 57
EC - Ecuador 51
PL - Polonia 49
IR - Iran 40
AU - Australia 37
GR - Grecia 37
BD - Bangladesh 31
CO - Colombia 31
CL - Cile 25
CD - Congo 24
TR - Turchia 24
MA - Marocco 22
PY - Paraguay 22
HR - Croazia 20
PT - Portogallo 19
RO - Romania 18
UZ - Uzbekistan 14
LT - Lituania 13
PH - Filippine 13
PK - Pakistan 13
CZ - Repubblica Ceca 12
EG - Egitto 12
IQ - Iraq 12
LB - Libano 10
MY - Malesia 10
AL - Albania 9
UY - Uruguay 9
NZ - Nuova Zelanda 8
SA - Arabia Saudita 8
TH - Thailandia 8
TN - Tunisia 7
DZ - Algeria 6
GT - Guatemala 6
HU - Ungheria 6
TW - Taiwan 6
AE - Emirati Arabi Uniti 5
BY - Bielorussia 5
DO - Repubblica Dominicana 5
KZ - Kazakistan 5
PE - Perù 5
BO - Bolivia 4
HN - Honduras 4
IL - Israele 4
KE - Kenya 4
LV - Lettonia 4
VE - Venezuela 4
AM - Armenia 3
AZ - Azerbaigian 3
NI - Nicaragua 3
OM - Oman 3
SM - San Marino 3
SV - El Salvador 3
YE - Yemen 3
AG - Antigua e Barbuda 2
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
DK - Danimarca 2
GA - Gabon 2
JM - Giamaica 2
KG - Kirghizistan 2
KH - Cambogia 2
KW - Kuwait 2
MT - Malta 2
NP - Nepal 2
PA - Panama 2
RS - Serbia 2
Totale 44.877
Salva come PNG Salva come JPEG
Città #
Singapore 2.701
Southend 2.422
Houston 2.128
Ashburn 1.524
Fairfield 1.471
Hefei 1.056
Hong Kong 1.044
Chandler 842
Dong Ket 680
Woodbridge 674
Santa Clara 652
Wilmington 631
Bologna 622
Seattle 616
Beijing 541
Princeton 526
Ann Arbor 471
Cambridge 471
Milan 469
Seoul 445
Boardman 418
Dublin 416
Jacksonville 382
Rome 349
Ho Chi Minh City 338
Munich 279
Hanoi 255
Abidjan 250
Padova 237
Nanjing 227
Westminster 219
New York 207
Bern 206
Los Angeles 206
Helsinki 195
Dallas 185
Berlin 165
Tokyo 164
Lomé 157
Florence 153
Buffalo 142
Jinan 123
Bengaluru 110
Abeokuta 109
Amman 107
Turin 106
San Diego 104
Shenyang 101
Saint Petersburg 100
Frankfurt am Main 98
Naples 96
Redondo Beach 96
Guangzhou 92
Brescia 85
Changsha 84
Sofia 81
Bremen 78
Mülheim 77
Shanghai 77
Medford 70
São Paulo 67
Tianjin 66
Dearborn 64
Hebei 64
Vienna 64
Falls Church 59
Nanchang 59
Zhengzhou 49
Hyderabad 48
Phoenix 48
Des Moines 46
Yubileyny 46
Brussels 44
Falkenstein 44
Jakarta 44
Palermo 43
Jiaxing 42
Mahé 42
Bari 41
Hangzhou 41
Nuremberg 41
Chicago 40
Verona 39
Washington 37
Ningbo 35
London 34
Redwood City 34
Haikou 33
Olalla 33
Toronto 33
Haiphong 32
Lagos 32
Lappeenranta 31
Norwalk 31
Council Bluffs 30
Parma 30
Rio de Janeiro 29
Tongling 29
Modena 28
Taiyuan 28
Totale 28.610
Salva come PNG Salva come JPEG
Nome #
New pathophysiological mechanisms in irritable bowel syndrome. 1.798
Italian guidelines for the management of irritable bowel syndrome: Joint Consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM), Hospital Gastroenterologists and Endoscopists (AIGO), Digestive Endoscopy (SIED), General Medicine (SIMG), Gastroenterology, Hepatology and Pediatric Nutrition (SIGENP) and Pediatrics (SIP) 1.195
Interazioni tra sistema serotoninergico e mediatori dell'infiammazione nella fisiopatologia della sindrome dell'intestino irritabile 689
Seasonal pattern of peptic ulcer hospitalizations: analysis of the hospital discharge data of the Emilia-Romagna region of Italy. 527
La sindrome dell'intestino irritabile. 303
Salmonella gastroenteritis during childhood is a risk factor for irritable bowel syndrome in adulthood 287
Randomised controlled trial of mesalazine in IBS 282
Chronic intestinal pseudo-obstruction related to viral infections. 280
Management of Irritable Bowel Syndrome With Diarrhea 265
Escherichia coli Nissle 1917 restores epithelial permeability alterations induced by irritable bowel syndrome mediators 265
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study 246
5-oxoETE triggers nociception in constipation-predominant irritable bowel syndrome through MAS-related G protein–coupled receptor D 245
Abnormalities of somatic peptide-containing nerves supplying the pelvic floor of women with genitourinary prolapse and stress urinary incontinence. 242
Collinsella aerofaciens as a predictive marker of response to probiotic treatment in non-constipated irritable bowel syndrome 239
Anti-ganglioside antibodies in coeliac disease with neurological disorders. 231
METODO E KIT PER LA DIAGNOSI DELLA SENSIBILITA’ AL GLUTINE NON ASSOCIATA ALLA CELIACHIA 231
Il sistema nervoso enterico. 227
Diagnosis and therapy of irritable bowel syndrome 226
A-Transducin, a Signaling Molecule of the Chemoreceptive Cascade, Is Expressed in Endocrine and Non-Endocrine Cells of the Pig Gastrointestinal Mucosa 215
Use of macrogol 4000 in chronic constipation. 214
Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. 213
A novel locus for syndromic chronic idiopathic intestinal pseudo-obstruction maps to chromosome 8q23-q24. 213
Advancements in drug development for diarrhea-predominant irritable bowel syndrome 205
beta3-adrenoceptors in the gut: evidence for a possible role in enteric neuroimmunomodulation 203
Chronic intestinal pseudo-obstruction: manifestations, natural history and management. 203
Sigmoid compliance and visceral perception in spinal cord injury patients 200
Aminosalicylates and other anti-inflammatory compounds for irritable bowel syndrome. 199
Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome 198
New insights into human enteric neuropathies. 196
X Congresso Nazionale delle Malattie Digestive AIGO-SIED-SIGE. 196
[Some practical questions on chronic stipsis treatment with prucalopride] 191
Effect of Lactobacillus paracasei CNCM I-1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial 191
Animal models of chemically induced intestinal inflammation: Predictivity and ethical issues 189
Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons 189
Chemosensitività intestinale, nervi, cellule enteroendocrine, recettori del gusto 187
Chronic intestinal pseudo-obstruction. 184
CLINICAL AND NEUROCHEMICAL FEATURES OF CHRONIC CONSTIPATION IN PATIENTS WITH PARKINSON DISEASE 184
Nerve fiber outgrowth is increased in the intestinal mucosa of patients with irritable bowel syndrome 183
H 2breath testing for other gas-related syndromes 180
New insights into irritable bowel syndrome pathophysiological mechanisms: contribution of epigenetics 179
MALATTIA DA REFLUSSO GASTROESOFAGEO 179
JC virus infects the enteric glia of patients with chronic idiopathic intestinal pseudo-obstruction. 179
null 179
Almost all irritable bowel syndromes are post-infectious and respond to probiotics: controversial issues. 176
A global perspective on irritable bowel syndrome: a consensus statement of the World Gastroenterology Organisation Summit Task Force on irritable bowel syndrome 175
Colonic immune cells in irritable bowel syndrome: A systematic review and meta-analysis 174
Serum zonulin and its diagnostic performance in non-coeliac gluten sensitivity 174
Pancreatic involvement in systemic sarcoidosis. A case report. 171
Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome. 171
Altered Serotonin Signaling and Extrinsic Sensory Neuron Activation in Irritable Bowel Syndrome 171
Neuropathological analisys and clinical correlates of chronic constipation in patients with parkinson’s disease 170
Mechanisms underlying visceral hypersensitivity in irritable bowel syndrome 169
Elucidating the gut microbiome of ulcerative colitis: bifidobacteria as novel microbial biomarkers 169
Lactiplantibacillus plantarum (CECT7484 and CECT7485) and Pedioccoccus acidilactici (CECT7483) enhance actin cytoskeleton and CYP1A1 expression restoring epithelial permeability alterations induced by irritable bowel syndrome mediators 168
Paraneoplastic Syndrome 168
Chronic intestinal pseudo-obstruction: clinical features, diagnosis, and therapy. 166
A mediator cocktail released from mucosal biopsies of IBS patients excites human and guinea pig enteric neurons. 164
Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome. 164
Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier 164
Caratterizzazione genetico-molecolare e morfologica di un modello sperimentale di megacolon congenito non agangliare. 163
Changes of α-transducin immunoreactivity (IR) in the pig gastrointestinal (GI) mucosa evoked by fasting/refeeding. 163
Quantification and Potential Functions of Endogenous Agonists of Transient Receptor Potential Channels in Patients With Irritable Bowel Syndrome 161
Mutations in RAD21 Disrupt Regulation of APOB in Patients With Chronic Intestinal Pseudo-Obstruction. 161
Functional variants in the sucrase-isomaltase gene associate with increased risk of irritable bowel syndrome 161
Neuroplasticity of the enteric nervous system induced by inflammatory conditions in the gut 160
Expression and regulation of α-transducin in the pig gastrointestinal tract 160
A case of paraneoplastic inflammatory neuropathy of the gastrointestinal tract related to an underlying neuroblastoma: successful management with immunosuppressive therapy. 160
Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease 159
Diagnostic challenges of symptomatic uncomplicated diverticular disease 159
Gastroesophageal reflux disease: clinical and pathophysiological features (part I)] 158
Post-infectious Irritable Bowel Syndrome. 157
5-HT7 Receptors Modulate Peristalsis and Accommodation in the Guinea Pig Ileum 157
Interferon-γ is increased in the gut of patients with irritable bowel syndrome and modulates serotonin metabolism 157
Interactions between commensal bacteria and gut sensorimotor function in health and disease. 156
Gastroesophageal reflux disease: therapeutic features (Part II)] 156
Serine proteases: new players in diarrhoea-predominant irritable bowel syndrome 156
Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. 156
Sensorineural hearing loss and celiac disease: a coincidental finding 156
Geraniol Treatment for Irritable Bowel Syndrome: A Double-Blind Randomized Clinical Trial 155
Clinical approach to diarrhea 155
Fecal Clostridiales distribution and short-chain fatty acids reflect bowel habits in irritable bowel syndrome 155
Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study. 154
Aspetti clinici ed anticorpi anti-neurone nella malattia celiaca con disordini neurologici 153
Antiflagellin antibodies suggest infective participation in irritable bowel syndrome pathogenesis. 153
Unsolved problems in the management of patients with gastro-oesophageal reflux disease 152
Gut microbiota and related diseases: clinical features. 152
Gastro-oesophageal reflux and interstitial lung disease. 152
Non-celiac gluten sensitivity in the context of functional gastrointestinal disorders 152
Actual therapy of gastroesophageal reflux disease 151
Delayed gastric emptying in functional dyspepsia 151
Evidence of RET/GDNF-related apolipoprotein B (APOB) activation and altered expression in patients with chronic intestinal pseudo-obstruction (CIPO) 151
The immune system in irritable bowel syndrome. 151
Neuroplasticità gastroenterica: dai geni all’infiammazione. 150
Inflammation as a cause of functional bowel disorders. 149
Role for protease activity in visceral pain in irritable bowel syndrome. 149
Enteric neuropathy evoked by repeated cisplatin in the rat. 149
A new reliable method for evaluating gallbladder dynamics the 3-dimensional sonographic examination 149
Molecular Mechanisms Underlying Loss of Vascular and Epithelial Integrity in Irritable Bowel Syndrome 148
Thrombotic thrombocytopenic purpura mimicking an acute meningoencephalitis. 147
Mast cell neuromuscolar involvement in patients with severe gastrointestinal dysmotility (SGID). 146
Totale 21.681
Salva come PNG Salva come JPEG
Categoria #
all - tutte 125.246
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 125.246
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.422 0 0 0 0 0 198 81 237 345 274 178 1.109
2021/20225.375 526 174 269 250 400 276 141 297 189 243 1.840 770
2022/20235.221 498 718 318 601 338 352 173 373 881 197 386 386
2023/20242.583 136 280 190 198 265 492 143 160 104 231 198 186
2024/20258.919 408 1.095 805 655 1.282 529 759 462 333 513 622 1.456
2025/202610.121 1.562 2.128 1.938 1.622 1.967 904 0 0 0 0 0 0
Totale 45.740